Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification

Medial vascular calcification has emerged as a key factor contributing to cardiovascular mortality in patients with chronic kidney disease (CKD). Vascular smooth muscle cells (VSMCs) with osteogenic transdifferentiation play a role in vascular calcification. Nicotinamide adenine dinucleotide phospha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: En-Shao Liu, Nai-Ching Chen, Tzu-Ming Jao, Chien-Liang Chen
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/4eb960f8fe464f61b6384cfebf7bfc9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4eb960f8fe464f61b6384cfebf7bfc9f
record_format dspace
spelling oai:doaj.org-article:4eb960f8fe464f61b6384cfebf7bfc9f2021-11-25T17:54:58ZDextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification10.3390/ijms2222122771422-00671661-6596https://doaj.org/article/4eb960f8fe464f61b6384cfebf7bfc9f2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12277https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Medial vascular calcification has emerged as a key factor contributing to cardiovascular mortality in patients with chronic kidney disease (CKD). Vascular smooth muscle cells (VSMCs) with osteogenic transdifferentiation play a role in vascular calcification. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitors reduce reactive oxygen species (ROS) production and calcified-medium–induced calcification of VSMCs. This study investigates the effects of dextromethorphan (DXM), an NADPH oxidase inhibitor, on vascular calcification. We used in vitro and in vivo studies to evaluate the effect of DXM on artery changes in the presence of hyperphosphatemia. The anti-vascular calcification effect of DXM was tested in adenine-fed Wistar rats. High-phosphate medium induced ROS production and calcification of VSMCs. DXM significantly attenuated the increase in ROS production, the decrease in ATP, and mitochondria membrane potential during the calcified-medium–induced VSMC calcification process (<i>p</i> < 0.05). The protective effect of DXM in calcified-medium–induced VSMC calcification was not further increased by NADPH oxidase inhibitors, indicating that NADPH oxidase mediates the effect of DXM. Furthermore, DXM decreased aortic calcification in Wistar rats with CKD. Our results suggest that treatment with DXM can attenuate vascular oxidative stress and ameliorate vascular calcification.En-Shao LiuNai-Ching ChenTzu-Ming JaoChien-Liang ChenMDPI AGarticledextromethorphansmooth muscle cellarterial calcificationBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12277, p 12277 (2021)
institution DOAJ
collection DOAJ
language EN
topic dextromethorphan
smooth muscle cell
arterial calcification
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle dextromethorphan
smooth muscle cell
arterial calcification
Biology (General)
QH301-705.5
Chemistry
QD1-999
En-Shao Liu
Nai-Ching Chen
Tzu-Ming Jao
Chien-Liang Chen
Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
description Medial vascular calcification has emerged as a key factor contributing to cardiovascular mortality in patients with chronic kidney disease (CKD). Vascular smooth muscle cells (VSMCs) with osteogenic transdifferentiation play a role in vascular calcification. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitors reduce reactive oxygen species (ROS) production and calcified-medium–induced calcification of VSMCs. This study investigates the effects of dextromethorphan (DXM), an NADPH oxidase inhibitor, on vascular calcification. We used in vitro and in vivo studies to evaluate the effect of DXM on artery changes in the presence of hyperphosphatemia. The anti-vascular calcification effect of DXM was tested in adenine-fed Wistar rats. High-phosphate medium induced ROS production and calcification of VSMCs. DXM significantly attenuated the increase in ROS production, the decrease in ATP, and mitochondria membrane potential during the calcified-medium–induced VSMC calcification process (<i>p</i> < 0.05). The protective effect of DXM in calcified-medium–induced VSMC calcification was not further increased by NADPH oxidase inhibitors, indicating that NADPH oxidase mediates the effect of DXM. Furthermore, DXM decreased aortic calcification in Wistar rats with CKD. Our results suggest that treatment with DXM can attenuate vascular oxidative stress and ameliorate vascular calcification.
format article
author En-Shao Liu
Nai-Ching Chen
Tzu-Ming Jao
Chien-Liang Chen
author_facet En-Shao Liu
Nai-Ching Chen
Tzu-Ming Jao
Chien-Liang Chen
author_sort En-Shao Liu
title Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
title_short Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
title_full Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
title_fullStr Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
title_full_unstemmed Dextromethorphan Reduces Oxidative Stress and Inhibits Uremic Artery Calcification
title_sort dextromethorphan reduces oxidative stress and inhibits uremic artery calcification
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4eb960f8fe464f61b6384cfebf7bfc9f
work_keys_str_mv AT enshaoliu dextromethorphanreducesoxidativestressandinhibitsuremicarterycalcification
AT naichingchen dextromethorphanreducesoxidativestressandinhibitsuremicarterycalcification
AT tzumingjao dextromethorphanreducesoxidativestressandinhibitsuremicarterycalcification
AT chienliangchen dextromethorphanreducesoxidativestressandinhibitsuremicarterycalcification
_version_ 1718411860197244928